EquityPanditβs Outlook for Lupin for the weekΒ Β (Jan 15, 2018Β βΒ Jan 19, 2018) :Β LUPIN: Lupin closed the week on positive note gaining around 2.10%....
Lupin has received US health regulator’s approval for generic Tamiflu Capsules. The company stated that, it has received final approval for its Oseltamivir Phosphate Capsules...
EquityPanditβs Outlook for Lupin for the weekΒ Β (Β JanΒ 08, 2018Β βΒ Jan 12, 2018) :Β LUPIN: Lupin closed the week on positive note gaining around 1.70%. As...
Lupin for treating serious infections has launched Flucytosine capsules, in the American market. In a regulatory filing, Lupin stated that, the company has launched its...
EquityPanditβs Outlook for Lupin for the weekΒ (Β JanΒ 01, 2018Β βΒ Jan 05, 2018) :Β LUPIN: Lupin closed the week on positive note gaining around 1.50%....
Lupin has received final approval forΒ Calcipotriene Topical Solution, 0.005% (Scalp Solution), from USFDA. The company has received approval to market a generic version of Dovonex...
Lupin has received approval from theΒ US health regulator, for Tydemy drug that is used to prevent pregnancy. The companyΒ has receivedΒ final approval for itsΒ Tydemy (Drospirenone, Ethinyl...